Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5-a]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach

Author:

Kosugi Tomomi1,Mitchell Dale R.2,Fujino Aiko1,Imai Minoru1,Kambe Mika1,Kobayashi Shinji1,Makino Hiroaki1,Matsueda Yohei1,Oue Yasuhiro1,Komatsu Kanji1,Imaizumi Keiichiro1,Sakai Yuri1,Sugiura Satoshi1,Takenouchi Osami1,Unoki Gen1,Yamakoshi Yuko1,Cunliffe Vicky2,Frearson Julie2,Gordon Richard2,Harris C. John2,Kalloo-Hosein Heidi2,Le Joelle2,Patel Gita2,Simpson Donald J.2,Sherborne Brad2,Thomas Peter S.2,Suzuki Naotaka1,Takimoto-Kamimura Midori1,Kataoka Ken-ichiro1

Affiliation:

1. Teijin Institute for Bio-medical Research, Teijin Pharma Ltd., Hino, Tokyo 191-8512, Japan

2. BioFocus, Chesterford Research Park, Saffron Walden, Essex, CB10 1XL, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3